Gastrointestinal And Endoscopic Articles & Analysis
17 news found
WATS3D testing meets the five pillars of evidence-based medicine typically required by insurance payors: analytic validity, clinical validity, clinical utility, cost-effectiveness, and recommendations by major medical societies. The American Society for Gastrointestinal Endoscopy (ASGE), the Society of American Gastrointestinal and Endoscopic ...
Data presentations include review of the VE303 Phase 2 CONSORTIUM study, in which VE303 was well tolerated and highly active at preventing Clostridioides difficile infection recurrence in subjects at high risk of recurrence Further CONSORTIUM study analysis shows that the VE303 high dose led to more robust colonization, which in turn correlated with prevention of recurrence Safety and ...
WATS3D testing meets the five pillars of evidence-based medicine typically required by insurance payors: analytic validity, clinical validity, clinical utility, cost-effectiveness, and recommendations by major medical societies. The American Society for Gastrointestinal Endoscopy (ASGE), the Society of American Gastrointestinal and Endoscopic ...
The gold standard in the diagnosis of IBD is gastrointestinal endoscopy with additional biopsy. However, this is an invasive and also cost-intensive examination. In addition to endoscopic examination, quantification of inflammatory biomarkers in stool samples of patients with suspected IBD is supported. ...
(Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, announced data from a Pooled-Analysis of Studies LBS-IST-POI-101 and LBS-POI-201-CN (PROFILE-CN.) These data are featured today at the Next Big Thing session of the Society of American Gastrointestinal and ...
(Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, was selected to present an ePoster entitled “Pooled-Analysis of Incidence and Severity of Post-Surgical Intraabdominal Adhesions following Bowel Resection Surgery and Treatment with Enteral Protease Inhibitor LB1148” at The Next Big ...
A newly published study as lead article in Gastrointestinal Endoscopy shows that Barrett’s esophagus (BE) and dysplasia progress to esophageal cancer at similar, or even higher, rates when diagnosed by WATS3D (wide-area transepithelial sampling with three-dimensional analysis) as they do when diagnosed by conventional forceps biopsies. ...
” The ArthroFree™ system will be available for viewing and hands-on demonstration at three upcoming conferences: The Annual Meeting of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), March 16-19, in Denver (Booth 202) The Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), March 22-26, in Chicago ...
This past summer, the ArthroFree system won the prestigious inaugural ACE Award for Innovation at the annual meeting of the American Orthopaedic Society for Sports Medicine and was one of three finalists in the Shark Tank competition at the annual meeting of the Society of American Gastrointestinal and Endoscopic Surgeons. In December, MedTech Outlook magazine ...
In announcing the Top 10 Endoscopy Device Providers for 2021, the magazine wrote: “The increasing demand for minimally invasive surgeries, and rising adoption of endoscopes for treatment and diagnosis, along with the ever-evolving healthcare technology realm, is breathing a fresh air of innovation into the endoscopy devices market…. ...
WATS3D testing meets the five pillars of evidence-based medicine typically required by insurance payors: analytic validity, clinical validity, clinical utility, cost-effectiveness, and recommendations by major medical societies. The American Society for Gastrointestinal Endoscopy (ASGE), the Society of American Gastrointestinal and Endoscopic ...
The E-View.AI provides leading-edge AI-enabled technology that dramatically reduces radiation exposure to patients and staff during endoscopic procedures. The Omega System offers several advantages that conventional fluoro systems cannot: Reduces radiation exposure to patients and staff by up to ~84% Delivers the highest level of image quality for the region of interest (ROI) ...
In this study, we found that combining one-time Revita DMR treatment with GLP-1RA medication could successfully eliminate insulin therapy for a majority of patients, whereas earlier studies of a GLP-1RA medication alone have not been able to demonstrate such findings[1],” said Jacques Bergman, M.D., Ph.D., a professor of gastrointestinal endoscopy at Amsterdam UMC and ...
MENLO PARK, California, October 9, 2020 — Galaxy Medical, (Galaxy), a developer of Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias, today announced that the first patients were successfully treated with the proprietary CENTAURI™ System by Dr. Ante Ani in Split, Croatia as part of the ECLIPSE-AF study. This multicenter trial is designed to assess the ...
EndoClot® SIA is the first starch-derived submucosal injection system cleared in the U.S. market for endoscopic removal of polyps, adenomas, early stage cancers and other gastrointestinal mucosal lesions. ...
Clinical trial published in peer-reviewed journal demonstrates diagnostic yield from Cellvizio®significantly exceeds standard of care (84.1% vs 34.1%); use of Cellvizio drives overall change in clinical management - including need for continued surveillance or surgery - in 42.3% of cases Mauna Kea Technologies today announced a publication that demonstrates how Cellvizio positively impacts ...
EndoClot Plus, Inc., a privately held medical device company founded by surgeons and biomaterial scientists announces the CE approval of EndoClot® Adhesive manufactured by EndoClot Plus Co., Ltd. located in Suzhou, China. The product will be made available for discussion during the upcoming Digestive Disease Week held in Washington DC, June 2-5, 2018. EndoClot® Adhesive is a single-use ...